PreveCeutical Medical Inc.
PRVCF
$0.0136
-$0.0009-6.21%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 6.92% | -51.49% | 43.86% | -74.03% | -4.14% |
| Total Depreciation and Amortization | 5.56% | -5.26% | 5.56% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.19% | -1.19% | -34.45% | 45.84% | -3.62% |
| Change in Net Operating Assets | 50.53% | -7.49% | -63.20% | 142.01% | 299.50% |
| Cash from Operations | 41.21% | -221.71% | -58.61% | 24.38% | 58.17% |
| Capital Expenditure | 0.00% | 83.33% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00% | 83.33% | -- | -- | -- |
| Total Debt Issued | -85.38% | 158.28% | 62.37% | -23.46% | -55.00% |
| Total Debt Repaid | 98.61% | -- | -- | -- | -- |
| Issuance of Common Stock | -14.93% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -40.88% | 209.60% | 64.10% | -24.59% | -54.98% |
| Foreign Exchange rate Adjustments | 108.33% | -1,300.00% | 150.00% | 71.43% | -187.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.00% | -290.00% | 600.00% | 66.67% | 77.78% |
